Drug and Therapeutics Update

National Institute for Health and Clinical Excellence 
NICE has rejected omalizumab for severe, persistent allergic asthma in adults and children because of doubts about the relevance of research evidence and about its cost effectiveness, but people already taking it may continue to do so until they and their doctors agree that stopping is appropriate.
To read more on this article click here >>

NICE turns down treatment for bladder cancer
To read more on this article click here >>

Department of Health 
Rotavirus vaccination of babies will begin next September
To read more on this article click here >>

Health Protection Agency 
Quarter of young who inject drugs still share needles and syringes
To read more on this article click here >>

HPA seeks to avert disaster of antibiotic resistance by raising awareness further
To read more on this article click here >>

One thought on “Drug and Therapeutics Update

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s